Tuberculosis and HIV infection - Main diagnostic and therapeutic problems;Gruźlica a zakażenie HIV - Główne problemy diagnostyczne i terapeutyczne

Polski Merkuriusz Lekarski

Volumn 23, Issue 135, 2007, Pages 212-214

  Dabrowska, Magdalena M ^a   Pogorzelska, Joanna ^a   Parfieniuk, Anna ^a   Siwak, Ewa ^a   Wiercińska Drapało, Alicja ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Diagnosis; HIV; Multi drug resistant tuberculosis; Mycobacterium tuberculosis; Treatment

Indexed keywords

ANTIINFECTIVE AGENT;

CD4 LYMPHOCYTE COUNT; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MICROBIOLOGY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; REVIEW; TUBERCULIN TEST;

ANTI-INFECTIVE AGENTS; CD4 LYMPHOCYTE COUNT; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HIV INFECTIONS; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 35048823405     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. API Consensus Expert Committee. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations. J. Assoc. Physicians India, 2006, 54, 219-234.
2. Cailhol J., Pizzocolo C., Brauner M. i wsp.: A delayed immune reconstitution inflammatory syndrome. AIDS, 2007, 21, 115-116.
3. Dhingra V.K., Rajpal S., Aggarwal N. i wsp.: Adverse drug reactions observed during DOTS. J. Commun. Dis., 2004, 36, 251-259.
4. Forget E.J., Menzies D.: Adverse reactions to first-line antituberculosis drugs. Expert Opin. Drug Saf., 2006, 5, 231-249.
5. Harries A.D.: Tuberculosis and human immunodeficiency virus infection in developing countries. Lancet, 1990, 335, 387-390.
6. Jones B.E., Young S.M., Antoniskis D. i wsp.: Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am. J. Respir. Crit. Care Med. ,1994, 150, 595-596.
7. Jubelt B.: Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. Curr. Neurol. Neurosci. Rep., 2006, 6, 451-452.
8. Mayanja-Kizza H., Jones-Lopez E., Okwera A. i wsp.: Uganda-Case Western Research Collaboration: Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda. J. Infect. Dis., 2005, 191, 856-865.
9. Narain J.P., Lo Y.R.: Epidemiology of HIV-TB in Asia. Indian J. Med. Res., 2004, 120, 277-289.
10. Olczak A.: Leczenie i profilaktyka chorób wskaźnikowych dla AIDS. W: HIV/AIDS. Podrecznik dla lekarzy i studentów. Halota W., Juszczyk J. (red.). Wydawnictwo Termedia, Poznań, 2006, 152-156.
11. Ozkutuk A., Kirdar S., Ozden S i wsp.: Evaluation of Cobas Amplicor MTB test to detect Mycobacterium tuberculosis in pulmonary and extra-pulmonary specimens. New Microbiol., 2006, 29, 269-273.
12. Palmero D., Ritacco V., Ambroggi M. i wsp.: Multidrug-resistant tuberculosis in AIDS patients at the beginning of the millennium. Medicina (B. Aires), 2006, 66, 399-404.
13. Richeldi L.: Rapid identification of Mycobacterium tuberculosis infection. Clin. Microbiol. Infect., 2006, 12, supl. 9, 34-36.
14. Saltini C.: Chemotherapy and diagnosis of tuberculosis. Respir. Med., 2006, 100, 2085-2097.
15. Sharma S.K., Mohan A., Kadhiravan T.: HIV-TB co-infection: epidemiology, diagnosis & management. Indian J. Med. Res., 2005, 121, 550-567.
16. Tenover F.C.: Rapid detection and identification of bacterial pathogens using novel molecular technologies: infection control and beyond. Clin. Infect. Dis., 2007, 44, 418-423.
17. Udjo E.G.: Estimation of mortality from vital registrations in South Africa. Curr. HIV Res., 2006, 4, 469-474.
18. UNAIDS, WHO. 06 Report on the global AIDS epidemic AIDS epidemic update: Joint United Nations Programme on HIV/AIDS, http://data.unaids.org/ pub/GlobalReport/2006/2006_GR-
19. Zielonka T.M.: Tuberculosis in Poland, Europe, and world. Part II: mortality, drug resistance and HIV infection. Pol. Merk. Lek., 2006, 21, 253-261.